DocMorris AG ZRE

Morningstar Rating
€20.24 −0.14 (0.69%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ZRE is trading at a LOCK|&$!%@ premium.
Price
€20.32
Fair Value
LOCK|.$!^S?>B
Uncertainty
LOCK|r#F
1-Star Price
LOCK|.tYG^DJ
5-Star Price
LOCK|.&LpwM<%
Economic Moat
LOCK|$>
Capital Allocation
—

Trading Information

Previous Close Price
€20.38
Day Range
€20.24–20.24
52-Week Range
€4.31–—
Bid/Ask
€20.34 / €20.92
Shares Outstanding
50.98M
Market Cap
CHF 1.03B
Volume/Avg
— / 1,480

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
0.63
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

DocMorris AG operates several e-commerce pharmacies for medical and pharmaceutical products and offers professional health care services. The Company operates at the intersection of healthcare, technology, and e-commerce, with a primary focus on creating a digital health platform. Its Online pharmacy business covers the online distribution of prescription and OTC medications, health, beauty and personal care products, while Digital services cover marketplace, ecosystem, technology and telemedicine services. Customer-centric AI-powered health services provide patients with comprehensive support and care through a seamless, personalised experience. Sales are made to mail-order pharmacies and directly to private individuals. The Group's reportable segments are Germany and Europe.
Sector
Healthcare
Industry
Pharmaceutical Retailers
Stock Style Box
Small Value
Total Number of Employees
1,576

Valuation

Metric
ZRE
Price/Earnings (Normalized)
—
Price/Book Value
2.57
Price/Sales
0.63
Price/Cash Flow
—
Price/Earnings
No chart available

Financial Strength

Metric
ZRE
Quick Ratio
1.39
Current Ratio
1.87
Interest Coverage
−5.49
Quick Ratio
ZRE

Profitability

Metric
ZRE
Return on Assets (Normalized)
−15.47%
Return on Equity (Normalized)
−31.11%
Return on Invested Capital (Normalized)
−16.17%
Return on Assets
ZRE

Pharmaceutical Retailers Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
JD Health International Inc
JDHIF
—LOCK|Q%LNf$17B
JD Health International Inc ADR
JDHIY
—LOCK|C&!S$17B
Alibaba Health Information Technology Ltd
ALBHF
—LOCK|H>g>$6B
Alibaba Health Information Technology Ltd ADR
ALBBY
—LOCK|P#c?t$6B
Raia Drogasil SA ADR
RADLY
—LOCK|P@SX$$4B
Sugi Holdings Co Ltd
SGIPF
—LOCK|JL$3B
COSMOS Pharmaceutical Corp
CSMYF
—LOCK|?B$3B
Clicks Group Ltd
CCKRF
—LOCK|g%?X$3B
Clicks Group Ltd ADR
CLCGY
—LOCK|$k%p>$3B
Redcare Pharmacy NV ADR
SAEYY
—LOCK|$^@$2B

Sponsor Center